Insider activity · ABBV · Healthcare

AbbVie Inc (ABBV) director acquisition adds insider angle to a strong tape

The disclosure gives investors a governance marker as the drugmaker trades with heavier turnover and firm relative performance.

AbbVie Inc
Latest253.35 USD
1W move17.0%
Volume2.6x
TrendInactive
AbbVie pharmaceutical manufacturing equipment with market data screens in a healthcare finance setting.

Market update

What happened

AbbVie Inc (ABBV) disclosed insider activity dated May 8, with director Jennifer L. Davis acquiring 1,118 shares of common stock at a reported transaction price of $0.00. The stock last closed at $253.35.

Weekly market data show a 17.0% one-week return and a 16.4% four-week return, with latest volume at 2.61 times the 13-week average. Market Dynamics is positive confirmation at 0.79 and Relative Strength is 9.3, though the trend signal remains inactive.

Continue your research

Explore ABBV across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

ABBV coverage

Evidence context